Articles · HRT

Stopping HRT: Symptoms and Timeline

Most women get symptoms back however they stop, and tapering rarely changes that.

6 min read · Published May 30, 2026 · Updated September 9, 2026

Sourced from peer-reviewed research and clinical guidelines, cited at the end of this article. How we write about your body.

Stopping HRT: Symptoms and Timeline

The decision to start HRT gets a lot of clinical attention. The decision to stop gets far less. For women who have used HRT for years, the practical questions are: what happens when you stop, does it matter how you stop, and when is the right time?

The evidence on these questions is more specific than most clinicians pass on, especially on how symptoms come back, the limited role of tapering, and which protective effects fade fast versus slowly.

Symptoms Coming Back

The most consistent finding across studies is that most women who stop HRT after long-term use get their hot flashes and other menopausal symptoms back.

A follow-up study of women who stopped after long-term use found that 93% had symptoms return within the first year.[1] Sleep problems (52%), hot flashes (45%), and mood changes were the most common. By three years after stopping, though, most women had no symptoms.[1]

That three-year path matters. Symptoms coming back after stopping does not mean they are permanent. For most women the body reaches a new hormonal balance and symptoms ease over one to three years.

Tapering Versus Stopping Abruptly

Whether to taper slowly or stop all at once is the most common practical question. The research is mixed.

Four randomised trials have directly compared gradual tapering with stopping abruptly.[2][3] The findings split evenly:

The most cited study concluded directly that gradually stopping hormone therapy only postpones, and does not prevent or reduce, the return of hot flashes, mood decline, and sexual problems.[2]

Despite this, most clinicians recommend tapering. That is reasonable caution where the evidence is uncertain: there is no evidence tapering is worse, and for women anxious about stopping, a gradual process may feel better. The practical point is that women who taper should not read a smoother first few weeks as a sign they have escaped the rebound. The same symptoms usually appear once the taper is complete.

What Protection You Lose

HRT’s protective effects on long-term health hold while treatment continues and fade after stopping.

Bone density. The gains or preservation from HRT are partly or fully lost in the years after stopping. Bone loss after stopping runs faster than the age-related rate for about one to two years before returning to the expected background trajectory.[4] Women using HRT specifically to prevent osteoporosis should discuss switching to another bone-protective medication rather than simply stopping.

Heart protection. The heart benefit of HRT started early in the transition (within the first ten years after menopause or before age 60, as established by the WHI and ELITE trials) comes from keeping the vessels healthy during the window when estrogen normally provides that support. After stopping, heart risk returns to the path expected without HRT: not a sudden jump, but the gradual loss of the protection built up in that window.

Genital and urinary tissue. GSM symptoms managed by the estrogen in HRT usually return after stopping systemic treatment. Local vaginal estrogen is separate from systemic HRT and can be continued indefinitely to maintain genital and urinary health, whether or not systemic HRT continues.

When Stopping Makes Sense

There is no universal time limit on HRT. Current guidelines from NAMS, NICE, and the British Menopause Society say duration should be individual, based on the woman’s reasons for using it, her risk profile, and her preferences. HRT should not be stopped at an arbitrary age or after a fixed number of years just as a precaution.

Common reasons to consider stopping:

Symptoms have resolved. For a woman who started HRT in early perimenopause for severe hot flashes and is now several years postmenopause, a trial off HRT is reasonable to see whether symptoms have naturally settled. Many women find they have no symptoms after stopping.

Risk profile has changed. A new diagnosis, a change in family history, or a significant heart event may shift the balance. These decisions should be made with a clinician.

Personal preference. Wanting to stop is a legitimate reason, and it deserves the same care as any other. The conversation should cover the expected symptom path, which protective effects will fade and over what time, and whether non-hormonal alternatives fit, so the decision is made with a full picture rather than a general reassurance that stopping is safe.

How to Stop

If you and your doctor decide to stop, the three practical parts, how to reduce the dose, how to manage symptoms during the change, and what to keep locally, are best handled together rather than one at a time.

Tapering over two to three months is a reasonable starting point, by reducing the dose, switching to a lower strength, or cutting days per week. Alongside that, plan behavioural support: pelvic floor exercises, cool bedding, and CBT-I for sleep can reduce symptom burden without extra medication. Non-hormonal medications (fezolinetant, SSRIs, or gabapentin) are available if hot flashes become significant and the decision to stay off systemic HRT holds. If GSM was a problem on systemic therapy, continue local vaginal estrogen. Stopping systemic HRT does not require stopping local vaginal treatment, and the two are clinically independent.

Arrange follow-up. If symptoms are severe three months after stopping, the conversation about restarting should stay open.


References

[1] Ockene, J. K., Barad, D. H., Cochrane, B. B., et al. (2005). Symptom experience after discontinuing use of estrogen plus progestin. JAMA, 294(2), 183-193. See also: Menopausal symptoms after cessation of hormone replacement therapy. https://pubmed.ncbi.nlm.nih.gov/16051451/

[2] Aslan, E., Bagis, T., Killic, G. S., Sofuoglu, K., Esen, O., Tarim, E. (2007). How best is to discontinue postmenopausal hormone therapy: immediate or tapered? Maturitas, 56(1), 78-83. https://pubmed.ncbi.nlm.nih.gov/17046182/

[3] Biglia, N., Maffei, S., Lello, S., Nappi, R. E. (2010). Tibolone in postmenopausal women: a review based on recent randomized controlled clinical trials. Gynecological Endocrinology, 26(11), 804-814. See also: A randomized controlled study of taper-down or abrupt discontinuation. https://pubmed.ncbi.nlm.nih.gov/19675505/ Note: tibolone is a synthetic steroid with pharmacology distinct from conventional estrogen-progestogen HRT; findings on tapering should be read with that difference in mind.

[4] Greendale, G. A., Espeland, M., Slone, S., Marcus, R., Barrett-Connor, E. (2002). Bone mass response to discontinuation of long-term hormone replacement therapy. Archives of Internal Medicine, 162(6), 665-672. https://doi.org/10.1001/archinte.162.6.665

Teala surfaces health patterns to help you and your doctor make informed decisions. It does not diagnose conditions or replace medical advice. Always consult a qualified healthcare professional about your symptoms and treatment.